P. Reed

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

V. Shinde, N. Patel, Haixia Zhou, 2020, The New England journal of medicine.

First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine

V. Shinde, N. Patel, M. Frieman, 2020, medRxiv.